|Description||(RS)-CPP, a piperazin derivative, has been found to be an effective NMDA antagonist.|
|Purity||≥95% by HPLC|
A caged version of D-AP5. D-AP5 is an antagonist of the NMDA receptor.
D-CPP-ene has been found to be an effective and competitive NMDA antagonist.
AM-36 is a potent blocker of batrachotoxinin (BTX)-sensitive Na+ channel binding in rat brain homogenates with an IC50 of 0.28 microM. As a unique neuroprotecti...
MDL-29951 is a novel glycine antagonist of NMDA receptor activation, with Ki of 0.14 μM for [3H]glycine binding in vitro and in vivo.
Traxoprodil mesylate is a NR2B selective antagonist of NMDA glutamate receptors.
PMPA (NMDA antagonist)
PMPA (NMDA antagonist) is a selective competitive antagonist at the NMDA receptor, with Ki= 0.84, 2.74, 3.53 and 4.16 μM at GluN2A, GluN2B, GluN2C and GluN2D su...
threo Ifenprodil hemitartrate
Threo Ifenprodil hemitartrate is the hemitartrate salt of threo ifenprodil, which is a NR2B subunit-selective NMDA receptor antagonist, as well as a potent σ re...
L-701,252 is an antagonist at the glycine-NMDA site with IC50 value of 420 nM. It is used as a potent systemic anticonvulsant.